Merck's Keytruda Data Brighten Picture For PD-1 Inhibitors In Myeloma
This article was originally published in The Pink Sheet Daily
Executive Summary
Data from the American Society of Hematology meeting suggest role for checkpoint inhibitors in hematology could extend past what looks like a sure thing in Hodgkin lymphoma, but it’s early days yet.